Deccan Health Care Limited has announced several key decisions made during its recent board meeting, including the reappointment of a director and the approval of its annual report.

Board Reappoints Ruchi Khattar as Independent Director

The Board of Directors has approved the reappointment of Ms. Ruchi Khattar as an Independent Director for a second term of five years, effective from September 4, 2025, to September 3, 2030. This decision is subject to shareholder approval at the upcoming Annual General Meeting (AGM).

Ms. Khattar, a graduate from Lady Sri Ram College, Delhi University, brings 25 years of experience in Accounts, Finance, and Insurance Compliance to the role. Her professional background includes senior positions at Max Bupa Health Insurance Company Limited and Max Insurance Company Limited.

Annual Report and AGM

The board has approved the annual report for the financial year ended March 31, 2025. The company's 29th AGM is scheduled for September 30, 2025, and will be conducted through video conferencing.

Appointment of Secretarial Auditors

The board has appointed M/s. M. R. Bhatia and Co., Practising Company Secretaries, as the company's Secretarial Auditors for five consecutive years, from FY 2025-26 to FY 2029-2030. This appointment is also subject to shareholder approval at the upcoming AGM.

M/s. M. R. Bhatia and Co., based in Ahmedabad, is a peer-reviewed firm known for its expertise in corporate law, SEBI regulations, and compliance services. The firm has been recognized by the Institute of Company Secretaries of India (ICSI) for maintaining high professional standards.

Other Board Decisions

The board has also:

1. Appointed M/s M. R. Bhatia & Co, Company Secretaries, Ahmedabad as the scrutinizer to oversee the e-voting process at the AGM.
2. Authorized Mr. Ronak Darji, Company Secretary, to determine the materiality of events or information for disclosures to the stock exchange.

These decisions reflect Deccan Health Care's commitment to maintaining strong corporate governance practices and ensuring compliance with regulatory requirements.

The board meeting, which commenced at 3:30 p.m. and concluded at 3:50 p.m., has set the stage for the company's operations and governance for the coming financial year.

Deccan Health Care Limited has announced the approval of its financial results for the first quarter of the fiscal year 2026. The company's Board of Directors convened a meeting via video conferencing on August 14, 2025, to review and approve the unaudited financial statements for the quarter ended June 30, 2025.

Key Highlights

• The board meeting was held on August 14, 2025, from 3:30 PM to 3:40 PM.
• Both standalone and consolidated unaudited financial results were approved for Q1 FY2026.
• The Audit Committee reviewed the financial results before the board's approval.
• Director Mohak Gupta has been authorized to sign the financial results.

Financial Results Approval Process

The company followed a structured approach in approving the financial results:

1. The Audit Committee conducted a thorough review of the financial statements.
2. Following the Audit Committee's recommendation, the Board of Directors approved both the standalone and consolidated unaudited financial results.
3. The approved results are accompanied by Limited Review Reports issued by the company's Statutory Auditors.

Compliance and Transparency

In line with regulatory requirements, Deccan Health Care Limited has taken several steps to ensure compliance and transparency:

• The financial results will be uploaded on the company's website at www.deccanhealthcare.co.in for public access.
• The company has submitted the required documents to the BSE Limited, including the unaudited financial results and Limited Review Reports.
• This action is in accordance with Regulation 33(3)(d) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Management Commentary

While specific financial figures were not disclosed in the announcement, the company's prompt reporting and adherence to regulatory guidelines demonstrate its commitment to transparency and good corporate governance practices.

Investors and stakeholders can access the detailed financial results on the company's website or through the BSE portal for a comprehensive understanding of Deccan Health Care Limited's performance in the first quarter of FY2026.

The timely approval and disclosure of financial results provide shareholders and potential investors with the latest information to make informed decisions about their investments in Deccan Health Care Limited.